Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Licofligozin for the treatment of non-alcoholic steatohepatitis

Licofligozin for the treatment of non-alcoholic steatohepatitis

US Patent 11179364 · Granted Nov 23, 2021

Estimated economic value: $11,822,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Uses of myostatin antagonists, combinations containing them and uses thereof2022
Pharmaceutical compositions comprising an aromatse inhibitors2018
Use of an aromatase inhibitor for the treatment of hypogonadism and related dise2017
Pharmaceutical compositions comprising an aromatse inhibitors2016
Use of an aromatase inhibitor for the treatment of hypogonadism and related dise2016
Antibodies and methods for WNT pathway-related diseases2016
Human C3b/C4b receptor (CR1)2001
Human C3b/C4b receptor (CR1)1999
Human C3b/C4b receptor (CR1)1999
Method of treating complement mediated disorders1995
Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, an1993
Nucleic acids encoding a human C3b/C4b receptor (CR1)1993